Skip to main content
. 2022 May 23;12:859721. doi: 10.3389/fonc.2022.859721

Table 2.

Characteristics and univariate analysis of PFS in the participants with NPC.

Covariates R (n = 32) NR (n = 10) p value Univariate analysis
HR (95% CI) p value
Age (years) 48.8 ± 7.4 57.7 ± 13.3 0.068 1.087 (1.01, 1.12) 0.023
Gender 0.606
 Male 24 (75.0) 6 (60.0) Reference
 Female 8 (25.0) 4 (40.0) 1.34 (0.37, 4.77) 0.656
Smoker 0.117
 No 18 (56.2) 9 (90.0) Reference
 Yes 14 (43.8) 1 (10.0) 0.10 (0.01, 0.85) 0.035
Alcohol abuse 1.000
 No 28 (87.5) 9 (90.0) Reference
 Yes 4 (12.5) 1 (10.0) 0.60 (0.07, 4.90) 0.635
Clinical stage 0.001
 I + II + III 26 (81.2) 2 (20.0) Reference
 IVa + IVb 6 (18.8) 8 (80.0) 7.66 (1.61, 36.43) 0.011
Dubosiella 1.69 (1.16, 2.48) 0.007
Bifidobacterium 3.78 (1.45, 9.87) 0.006
Turicibacter 5.11 (2.04, 12.77) <0.001
Clostridium_sensu_stricto_1 1.06 (1.01, 1.11) 0.012

The values are presented as the mean ± standard deviation (SD) or n (%) unless otherwise stated.

R, Patients without progressive disease after standard treatments; NR, Patients with progressive disease after standard treatments. p < 0.05 (the bold values) in the table indicates a statistical significance.